SE0104462D0 - Peptide purifcation (Peptidrening) - Google Patents

Peptide purifcation (Peptidrening)

Info

Publication number
SE0104462D0
SE0104462D0 SE0104462A SE0104462A SE0104462D0 SE 0104462 D0 SE0104462 D0 SE 0104462D0 SE 0104462 A SE0104462 A SE 0104462A SE 0104462 A SE0104462 A SE 0104462A SE 0104462 D0 SE0104462 D0 SE 0104462D0
Authority
SE
Sweden
Prior art keywords
sub
solvent
water
mixture
decapeptide
Prior art date
Application number
SE0104462A
Other languages
English (en)
Swedish (sv)
Inventor
Jon H Rasmussen
Palle H Rasmussen
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Priority to SE0104462A priority Critical patent/SE0104462D0/xx
Publication of SE0104462D0 publication Critical patent/SE0104462D0/xx
Priority to US10/500,302 priority patent/US7057014B2/en
Priority to IL16278902A priority patent/IL162789A0/xx
Priority to DK02783479.5T priority patent/DK1468009T3/da
Priority to NZ534151A priority patent/NZ534151A/en
Priority to CNB028283481A priority patent/CN1272341C/zh
Priority to AU2002347550A priority patent/AU2002347550B2/en
Priority to AT02783479T priority patent/ATE449784T1/de
Priority to KR1020047010363A priority patent/KR100880828B1/ko
Priority to PCT/IB2002/005581 priority patent/WO2003055900A1/en
Priority to ES02783479T priority patent/ES2350880T3/es
Priority to JP2003556430A priority patent/JP4378173B2/ja
Priority to RU2004119965/04A priority patent/RU2303040C2/ru
Priority to CA2471717A priority patent/CA2471717C/en
Priority to HK05108061.2A priority patent/HK1076112B/xx
Priority to DE60234535T priority patent/DE60234535D1/de
Priority to EP02783479A priority patent/EP1468009B1/en
Priority to ZA2004/05135A priority patent/ZA200405135B/en
Priority to IL162789A priority patent/IL162789A/en
Priority to NO20043046A priority patent/NO329024B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE0104462A 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening) SE0104462D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE0104462A SE0104462D0 (sv) 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening)
EP02783479A EP1468009B1 (en) 2001-12-29 2002-12-23 Peptide purification
KR1020047010363A KR100880828B1 (ko) 2001-12-29 2002-12-23 펩타이드 정제
ES02783479T ES2350880T3 (es) 2001-12-29 2002-12-23 Purificación de péptidos.
DK02783479.5T DK1468009T3 (da) 2001-12-29 2002-12-23 Peptidoprensning
NZ534151A NZ534151A (en) 2001-12-29 2002-12-23 A process of purification of an otherwise pure nona- or decapeptide from residual organic solvent
CNB028283481A CN1272341C (zh) 2001-12-29 2002-12-23 肽的纯化
AU2002347550A AU2002347550B2 (en) 2001-12-29 2002-12-23 Peptide purification
AT02783479T ATE449784T1 (de) 2001-12-29 2002-12-23 Peptid aufreinigung
US10/500,302 US7057014B2 (en) 2001-12-29 2002-12-23 Peptide purification
PCT/IB2002/005581 WO2003055900A1 (en) 2001-12-29 2002-12-23 Peptide purification
IL16278902A IL162789A0 (en) 2001-12-29 2002-12-23 Peptide furification
JP2003556430A JP4378173B2 (ja) 2001-12-29 2002-12-23 ペプチド精製
RU2004119965/04A RU2303040C2 (ru) 2001-12-29 2002-12-23 Очистка пептидов
CA2471717A CA2471717C (en) 2001-12-29 2002-12-23 Process of purification of a nona-or deca peptide from residual organic solvent
HK05108061.2A HK1076112B (en) 2001-12-29 2002-12-23 Peptide purification
DE60234535T DE60234535D1 (de) 2001-12-29 2002-12-23 Peptid aufreinigung
ZA2004/05135A ZA200405135B (en) 2001-12-29 2004-06-28 Peptide purification
IL162789A IL162789A (en) 2001-12-29 2004-06-29 Peptide purification
NO20043046A NO329024B1 (no) 2001-12-29 2004-07-16 Peptidrensing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0104462A SE0104462D0 (sv) 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening)

Publications (1)

Publication Number Publication Date
SE0104462D0 true SE0104462D0 (sv) 2001-12-29

Family

ID=20286556

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0104462A SE0104462D0 (sv) 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening)

Country Status (18)

Country Link
US (1) US7057014B2 (cg-RX-API-DMAC7.html)
EP (1) EP1468009B1 (cg-RX-API-DMAC7.html)
JP (1) JP4378173B2 (cg-RX-API-DMAC7.html)
KR (1) KR100880828B1 (cg-RX-API-DMAC7.html)
CN (1) CN1272341C (cg-RX-API-DMAC7.html)
AT (1) ATE449784T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002347550B2 (cg-RX-API-DMAC7.html)
CA (1) CA2471717C (cg-RX-API-DMAC7.html)
DE (1) DE60234535D1 (cg-RX-API-DMAC7.html)
DK (1) DK1468009T3 (cg-RX-API-DMAC7.html)
ES (1) ES2350880T3 (cg-RX-API-DMAC7.html)
IL (2) IL162789A0 (cg-RX-API-DMAC7.html)
NO (1) NO329024B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ534151A (cg-RX-API-DMAC7.html)
RU (1) RU2303040C2 (cg-RX-API-DMAC7.html)
SE (1) SE0104462D0 (cg-RX-API-DMAC7.html)
WO (1) WO2003055900A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200405135B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359722A1 (en) * 2002-03-27 2003-11-05 BRITISH TELECOMMUNICATIONS public limited company Data streaming system and method
AU2006207325B2 (en) 2005-01-21 2012-08-16 Astex Therapeutics Limited Pharmaceutical compounds
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US20120149868A1 (en) * 2008-05-15 2012-06-14 Novo Nordisk A/S Purification of peptides prepared by solid phase synthesis
DK2417152T3 (da) * 2009-04-10 2013-12-16 Corden Pharma Colorado Inc Fremgangsmåde til isolering af linaclotid
CN104837508A (zh) 2012-12-13 2015-08-12 免疫医疗公司 功效改进且毒性降低的抗体与sn-38的免疫缀合物的剂量
WO2015012904A2 (en) * 2012-12-13 2015-01-29 Immunomedics, Inc. Antibody-sn-38 immunoconjugates with a cl2a linker
US9931417B2 (en) 2012-12-13 2018-04-03 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
EP3024460B1 (en) * 2013-07-23 2020-07-22 Immunomedics, Inc. Method for producing antibody-sn-38 immunoconjugates with a cl2a linker
CN109310385A (zh) 2016-04-27 2019-02-05 免疫医疗公司 抗trop-2-sn-38抗体药物缀合物用于检查点抑制剂复发/难治的肿瘤的疗法的功效
CA3050332A1 (en) 2017-03-27 2018-10-04 Immunomedics, Inc. Treatment of trop-2 expressing triple negative breast cancer with sacituzumab govitecan and a rad51 inhibitor
WO2018187074A1 (en) 2017-04-03 2018-10-11 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
CN113952944B (zh) * 2021-12-23 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种纯化九肽-1的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317697D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Dissolution of peptides in non-aqueous and mixed non-aqueous/aqueous solvents
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19813849A1 (de) * 1998-03-27 1999-09-30 Degussa Verfahren zur einstufigen Umsalzung und Aufreinigung von Oligopeptiden
EP0998940A1 (en) * 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
ES2350880T3 (es) 2011-01-27
CA2471717C (en) 2013-06-18
KR20040090966A (ko) 2004-10-27
NO329024B1 (no) 2010-08-02
ZA200405135B (en) 2005-08-31
HK1076112A1 (en) 2006-01-06
RU2303040C2 (ru) 2007-07-20
EP1468009B1 (en) 2009-11-25
DE60234535D1 (de) 2010-01-07
JP2005515217A (ja) 2005-05-26
RU2004119965A (ru) 2006-01-10
AU2002347550A1 (en) 2003-07-15
AU2002347550B2 (en) 2008-01-03
US7057014B2 (en) 2006-06-06
EP1468009A1 (en) 2004-10-20
CA2471717A1 (en) 2003-07-10
WO2003055900A1 (en) 2003-07-10
CN1272341C (zh) 2006-08-30
IL162789A0 (en) 2005-11-20
DK1468009T3 (da) 2010-04-06
CN1625561A (zh) 2005-06-08
KR100880828B1 (ko) 2009-01-30
NO20043046L (no) 2004-08-30
ATE449784T1 (de) 2009-12-15
IL162789A (en) 2010-04-29
JP4378173B2 (ja) 2009-12-02
US20060014694A1 (en) 2006-01-19
NZ534151A (en) 2007-05-31

Similar Documents

Publication Publication Date Title
SE0104462D0 (sv) Peptide purifcation (Peptidrening)
CN101553574B (zh) 制备视黄酯的方法
MY142836A (en) Self-extinguishing catalyst composition with monocarboxylic acid ester internal donor and propylene polymerization process
BR9407052A (pt) Misturas de combustiveis
SI1515962T1 (sl) Postopek za pripravo dioksan estrov ocetne kisline
EP1568740A3 (en) Thickening systems and aqueous-coating compositions, and methods of making and using the same
CA2410451A1 (en) Clarification method for oil dispersions comprising overbased detergents containing calcite
DK0925065T3 (da) Vandblandbare erythromycinsammensætninger
AU552050B2 (en) N-substituted azeheterocyclic carboxylic acids and their esters
Ko et al. Generation of Diphenyldiazomethane by Oxidation of Benzophenone Hydrazone with Magtrieve [TM]
WO2004065358A3 (en) Method of reducing toxicity of retinoids
ATE258911T1 (de) Verfahren zur herstellung von alkoxyzimtsäureester
TW200519090A (en) Process for producing high purity 3, 5-dihydroxy-6-heptenoic acid derivative
WO2004069969A3 (de) Ester konjugiert ungesättigter carbonsäuren (konjugensäurester) verfahren zu ihrer herstellung und ihre verwendung
RU2000114008A (ru) Способ выделения кислот из углеводородных смесей
WO2002032849A3 (en) Ester compounds and their use in forming acrylates
TH63268A (th) การนำอะคริลิก แอซิดกลับคืนมา โดยใช้ เอธิล อะคริเลต และตัวทำละลายร่วม ที่เลือกมา
RU95120710A (ru) Способ герметизации трубопровода
NO20013528D0 (no) Fremgangsmåte for reduksjon av 3-dimetylamino-2- fenylpropionsyre-etylester-innhold i lösninger av 2-dimetylamino-1-fenyl-3-cykloheksen-1-karboksylsyre-etylester
JPS55139355A (en) Preparation of optically active thioester and optically active thiol which is derivative thereof
JPS53147063A (en) Preparation of alpha-acyloxythienyl acetic acids
KR880001631A (ko) 퀴놀린 유도체의 제조 방법